Sixth annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)

• Date:
  Thursday, 26 June 2014, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The sixth workshop of the European Network of Paediatric Research at the European Medicines Agency will take place on 26-27 June 2014 at the European Medicines Agency in London. Day one on the 26 June is an open meeting to all stakeholders: patient/parent organisations, network representatives, pharmaceutical industry staff responsible for paediatric studies and regulators. Day two on 27 June is dedicated to members of Enpr-EMA and its working groups. Registration open until 13 June 2014 using the registration form.

Documents

Report on annual workshop of the European network of paediatric research at the European Medicines Agency - 26-27 June 2014

Reference Number: EMA/500467/2014

Minutes of the annual European network of paediatric research at the European Medicines Agency members meeting - 26 June 2014

Reference Number: EMA/408421/2014

Minutes of the sixth European network of paediatric research at the European Medicines Agency coordinating group meeting - 27 June 2014

Reference Number: EMA/410668/2014

Agenda - Sixth annual workshop of the European network of paediatric research at the EMA (Enpr-EMA)

Reference Number: EMA/110531/2014

Agenda - Sixth annual face to face meeting of European network of paediatric research at the European Medicines Agency Coordinating Group members - 27 June 2014

Reference Number: EMA/245783/2014

Agenda of the sixth annual meeting of European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) members

Reference Number: EMA/245782/2014

Registration form - Sixth workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)

Announcement - Sixth Enpr-EMA workshop

Presentation - Industry representation within the Enpr-EMA Coordinating Group (Irmgard Eichler)

Presentation - Proposed amendment to the policy on transparency and handling of potential conflicts of interests (Irmgard Eichler)

Presentation - Endorsement of new or updated applications for Enpr-EMA membership (Benjamin Pelle)

Presentation - Cardiology network (Sylvie di Filippo)

Presentation - Diabetes and endocrinology network (David Dunger)

Presentation - Identifying centres and networks with the capacity and expertise to conduct PASS in children (Dirk Mentzer)

Presentation - EU reference network - Directive 2011-24-EU (Irmgard Eichler)

Presentation - Why consider involving paediatric networks when preparing the PIP (Irmgard Eichler)

Presentation - Opportunities for public-private partnerships in pediatric research networks (Charles Thomson)

Presentation - Worldwide involvement of children in clinical research (Pamela Dicks, Jenny Preston, Charles Thompson)

Presentation - Report from the coordinating group (CG): Update on Enpr-EMA activities achievements and challenges (Mark Turner)

Presentation - Update on Working Groups 3 and 5 (Susan Tansey)

Presentation - Update on Working Group 4 (Allison Needham, Pirkko Lepola)

Presentation - Update on Working Group 6 (Saul Faust, Ron Portman)

Presentation - III Revision of the guideline on conduct of pharmacovigilance for medicines used by the paediatric population (Dirk Mentzer)

Presentation - Update on Working Group 7 (Mark Turner)

Presentation - Update on Working Group 9 (Mark Turner)

Presentation - Update on Working Group 10 (Mark Turner)